A Study to Evaluate Atumelnant in Adults With Congenital Adrenal Hyperplasia

Clinical trial NCT07144163 · RECRUITING

Trial details

NCT number: NCT07144163
Sponsor: Crinetics Pharmaceuticals Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Adrenal Hyperplasia Classic Congenital Adrenal Hyperplasia

Start date: 2025-12-11
Primary completion: 2027-05-01
Enrollment: 150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.